sever
acut
respiratori
syndrom
sar
atyp
pneumonia
emerg
late
spread
two
dozen
countri
within
asia
south
north
america
europ
spring
period
sar
epidem
consid
signific
threat
popul
mortal
rate
approxim
respons
around
death
approxim
patient
sarscoronaviru
sarscov
novel
coronaviru
classifi
member
coronavirida
famili
soon
identifi
caus
pathogen
rna
genom
sarscov
consist
potenti
major
open
read
frame
encod
viral
nonstructur
protein
accesori
protein
structur
protein
includ
spike
membran
envelop
e
nucleocapsid
n
protein
angiotensinconvert
enzym
type
integr
transmembran
protein
identifi
function
receptor
sarscov
vitro
vivo
studi
express
protein
tissu
tropism
cellular
distribut
sarscov
provid
new
insight
mechan
pathogenesi
nevertheless
certain
endotheli
cell
human
intestin
cell
line
fail
infect
sarscov
contrast
cell
without
detect
express
level
hepatocyt
could
infect
sarscov
addit
presenc
alon
suffici
maintain
viral
infect
altogeth
observ
indic
differ
viru
receptor
coreceptor
may
util
infect
sarscov
variou
tissu
inde
dcsign
ctype
lectin
receptor
express
dendrit
cell
dcsignrel
molecul
lsign
also
name
dcsignr
indic
interact
sarscov
spike
protein
facilit
viru
dissemin
vimentin
major
compon
type
iii
intermedi
filament
protein
aim
mainli
maintain
architectur
cytoplasm
also
secret
certain
condit
vimentin
particip
cell
adhes
migrat
cellular
signal
addit
vimentin
report
play
role
viral
multipl
rearrang
cytosol
vimentin
format
vimentin
cage
around
viral
factori
observ
infect
vaccinia
viru
african
swine
fever
viru
studi
mammalian
porcin
reproduct
respiratori
syndrom
viru
japanes
enceph
viru
cowpea
mosaic
viru
also
provid
evid
bind
viru
surfac
vimentin
facilit
intern
infect
block
express
bind
surfac
vimentin
inhibit
viral
entri
studi
intermedi
filament
vimentin
identifi
cellular
factor
abundantli
present
sarscov
spike
complex
incub
vero
cell
sarscov
viruslik
particl
vlp
enhanc
express
level
surfac
form
vimentin
coloc
vimentin
sarscov
spike
protein
observ
short
time
period
soon
incub
studi
indic
vimentin
directli
bind
sarscov
spike
protein
involv
entri
sarscov
result
suggest
vimentin
serv
put
coreceptor
coordin
interact
sarscov
infect
studi
provid
new
target
drug
develop
sarscov
infect
spodoptera
frugiperda
insect
cell
maintain
suppli
medium
gibco
vero
cell
african
green
monkey
kidney
epitheli
cell
maintain
dulbecco
modifi
eagl
medium
gibco
supplement
heatinactiv
fetal
bovin
serum
penicillin
unitsml
streptomycin
product
purif
sarscov
vlp
sarscov
spike
protein
carri
describ
previous
brief
cell
coinfect
three
recombin
baculovirus
express
sarscov
e
protein
individu
condit
medium
contain
properli
assembl
vlp
harvest
day
postinfect
sarscov
vlp
purifi
sucros
gradient
centrifug
rpm
h
use
rotor
beckman
ultracentrifug
sarscov
vlp
analyz
immunogold
electron
microscopi
data
shown
addit
number
sarscov
vlp
calcul
atom
forc
microscopi
describ
previous
obtain
sarscov
spike
protein
cultur
medium
cell
previous
infect
recombin
baculovirus
express
ctermin
histag
fulllength
sarscov
spike
protein
collect
day
postinfect
subject
purif
spike
protein
use
sepharos
purif
system
extracellular
chemic
crosslink
vero
cell
preincub
sarscov
vlp
vlptocel
ratio
perform
h
mm
membraneimperm
primari
aminereact
crosslink
bi
sulfosuccinimidyl
suber
pierc
thiolcleav
reagent
dithiobi
sulfosuccinimidylpropion
dtssp
pierc
reaction
buffer
mm
nacl
pb
ph
reaction
mixtur
quench
mm
tri
buffer
ph
min
room
temperatur
subject
cell
lysi
identif
protein
follow
extracellular
chemic
crosslink
sarscov
vlppreincub
vero
cell
lyse
empigen
bb
lysi
buffer
mm
trishcl
ph
sodium
deoxychol
mm
nacl
mm
edta
empigen
bb
supplement
proteas
inhibitor
cocktail
roch
phenylmethylsulfonyl
fluorid
protein
lysat
subject
immunoprecipit
follow
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
silver
stain
lcmsm
analysi
describ
previous
flow
cytometri
analysi
perform
quantit
determin
cell
surfac
vimentin
vlpposit
spikeposit
cell
detect
surfac
vimentin
vero
cell
preincub
sarscov
vlp
vlptocel
ratio
min
cell
subsequ
fix
formaldehyd
fac
buffer
mm
edta
pb
ph
min
follow
incub
mous
antivimentin
antibodi
sigma
goat
antimous
alexafluor
antibodi
quantit
determin
vlpposit
cell
spikeposit
cell
vero
cell
preincub
sarscov
vlp
purifi
spike
protein
fix
fac
buffer
formaldehyd
permeabil
fac
buffer
triton
subject
immunofluoresc
label
goat
antimous
alexafluor
antibodi
follow
incub
epitop
antibodi
invitrogen
goat
antirabbit
alexafluor
antibodi
follow
incub
rabbit
antibodi
bethyl
laboratori
inc
respect
immunofluoresc
stain
cell
subject
lsrii
digit
flow
cytomet
bd
bioscienc
data
analyz
use
flowjo
softwar
tree
star
inc
antibodi
neutral
experi
rabbit
monoclon
antivimentin
antibodi
immuno
bioscienc
corp
mous
monoclon
antivimentin
antibodi
sigma
goat
polyclon
antibodi
r
system
appli
prior
treatment
sarscov
vlp
spike
protein
subsequ
flow
cytometri
vimentin
knockdown
experi
vero
cell
infect
lentivirus
carri
shrna
specif
vimentin
prior
treatment
spike
protein
subsequ
flow
cytometri
cell
grown
mm
round
glass
coverslip
fix
use
formaldehyd
pb
min
cell
rins
pb
buffer
subsequ
appropri
amount
acetonemethanol
solut
ad
incub
min
permeabil
cell
membran
pb
buffer
immedi
appli
follow
quick
rins
use
pb
buffer
studi
monitor
protein
cellular
membran
permeabil
step
skip
cell
treat
bsa
pb
buffer
block
h
primari
antibodi
pb
buffer
contain
bsa
overnight
next
day
cell
rins
pb
subsequ
incub
secondari
antibodi
pb
buffer
contain
bsa
h
room
temperatur
stain
nuclei
hoechst
pb
buffer
contain
bsa
ad
time
addit
secondari
antibodi
coverslip
treat
mount
fluid
seal
observ
certain
group
experi
aim
examin
surfac
vimentin
upon
sarscov
vlp
bind
vero
cell
preincub
sarscov
vlp
vlptocel
ratio
imag
acquir
leica
tc
confoc
microscopi
immunofluoresc
stain
assay
vero
cell
preincub
sarscov
vlp
fix
subject
analysi
describ
previous
use
mous
antivimentin
antibodi
sigma
rabbit
antisarscov
spike
protein
antibodi
imgenex
primari
antibodi
alexafluor
goat
antimous
igg
antibodi
alexafluor
goat
antirabbit
igg
antibodi
respect
secondari
antibodi
farwestern
blot
analysi
cell
lysat
resolv
sdspage
transfer
onto
pvdf
membran
follow
block
bsa
pb
buffer
membran
incub
purifi
sarscov
spike
protein
overnight
pb
buffer
contain
bsa
detect
bind
purifi
spike
protein
along
interact
cellular
protein
resolv
membran
detect
western
blot
analysi
describ
previous
lentiviru
vector
carri
small
hairpin
rna
shrna
target
vimentin
shvima
shvimb
shvimc
target
luciferas
shluc
nation
rnai
core
facil
academia
sinica
taiwan
individu
cotransfect
pmdg
cell
use
tpro
ntr
ii
transfect
reagent
tpro
biotechnolog
cultur
supernat
contain
lentivirus
carri
individu
shrna
harvest
use
knockdown
vimentin
express
vero
cell
follow
infect
addit
polybren
sigma
ad
increas
effici
infect
lentiviru
carri
shrna
luciferas
serv
neg
control
vimentin
knockdown
experi
examin
put
sarscov
spike
proteininteract
host
factor
sarscovpermiss
vero
cell
incub
sarscov
vlp
presenc
membraneimperm
trigger
chemic
crosslink
ntermin
domain
sarscov
spike
protein
function
receptor
well
compon
appear
spikereceptor
complex
vero
cell
lysat
immunoprecipit
antibodi
pretreat
purifi
sarscov
spike
protein
shown
form
variou
complex
molecular
size
larger
kda
data
shown
indic
numer
host
factor
associ
viral
complex
upon
bind
dissect
protein
involv
complex
revers
crosslink
dtssp
use
link
interact
partner
within
subsequ
dtssplink
protein
cleav
central
disulfid
bond
crosslink
ad
reduc
agent
prior
sdspage
follow
silver
stain
result
protein
band
seen
gel
refer
molecular
weight
compon
complex
compar
vero
cell
lysat
preincub
sarscov
vlp
time
cours
min
treat
vlp
min
refer
seven
major
protein
band
name
indic
black
arrowhead
show
differenti
abund
fig
band
cut
gel
sent
lcmsm
analysi
result
spectra
protein
demonstr
fragment
match
fraction
vimentin
protein
sequenc
suggest
cytoskelet
protein
vimentin
one
put
protein
inset
fig
confirm
interact
vimentin
protein
cell
lysat
prepar
sarscov
vlptreat
vero
cell
subject
coimmunoprecipit
antibodi
detect
antivimentin
antibodi
neg
control
experi
vero
cell
without
treatment
sarscov
vlp
shown
fig
vimentin
form
complex
vero
cell
pretreat
sarscov
vlp
min
nevertheless
interact
vimentin
complex
membran
transient
coimmunoprecipit
vimentin
longer
detect
min
result
suggest
involv
cell
surfac
vimentin
viru
entri
via
interact
rel
short
time
period
soon
expos
sarscov
vlp
complex
specul
regard
conflict
whether
vimentin
interact
min
fig
min
fig
given
discuss
section
examin
biolog
role
vimentin
associ
complex
express
vimentin
cellular
distribut
examin
immunofluoresc
assay
follow
pretreat
vero
cell
sarscov
vlp
min
shown
fig
vimentin
coloc
sarscov
spike
protein
cell
surfac
indic
white
arrow
nonperm
fixat
condit
allow
detect
protein
level
extracellular
side
neg
control
vero
cell
without
pretreat
sarscov
vlp
shown
detect
signal
refer
spike
protein
membran
although
background
nois
appear
antivimentin
antibodi
appli
detect
surfac
vimentin
coloc
spike
vimentin
observ
addit
cell
line
use
ensur
lack
cell
accommod
bind
spike
protein
membran
moreov
vimentin
show
correl
complex
term
distribut
fig
vero
cell
without
pretreat
sarscov
vlp
permeabil
acetonemethanol
vimentin
protein
detect
cytosol
quantifi
amount
surfac
vimentin
induc
sarscov
vlp
treatment
flow
cytometri
util
use
vero
cell
permeabil
triton
detect
intracellular
vimentin
posit
control
light
blue
peak
increas
cell
surfac
vimentin
upon
applic
sarscov
vlp
magenta
curv
detect
comparison
without
vlppretreat
grey
peak
fig
know
vimentin
present
viral
spike
complex
potenti
import
cell
entri
sarscov
vlp
vital
understand
interact
surfac
vimentin
spike
direct
indirect
conduct
farwestern
blot
analysi
direct
interact
viral
spike
protein
vimentin
conclud
fig
purifi
spike
protein
coloc
kda
vimentin
blot
membran
indic
direct
bind
spike
protein
vimentin
fig
left
panel
besid
membran
pretreat
antivimentin
antibodi
prior
spike
protein
incub
vimentin
detect
via
farwestern
blot
fig
right
panel
western
blot
analysi
antibodi
vimentin
perform
parallel
posit
control
fig
addit
coomassi
blue
stain
shown
fig
intern
control
aim
ensur
rel
abund
cellular
protein
kda
might
interfer
farwestern
blot
analysi
taken
togeth
data
suggest
involv
surfac
vimentin
viru
entri
via
interact
complex
specif
surfac
vimentin
involv
entri
sarscov
vlp
elucid
antibodi
neutral
experi
vero
cell
preincub
antivimentin
antibodi
rp
antibodi
control
antibodi
prior
treatment
sarscov
vlp
intracellular
vlp
monitor
flow
cytometri
use
antibodi
detect
membranepermeabil
sarscov
vlpposit
vero
cell
result
demonstr
reduct
vs
number
cell
uptook
sarscov
vlp
cell
pretreat
antivimentin
antibodi
cell
pretreat
antibodi
show
declin
vs
fig
result
suggest
antivimentin
antibodi
success
block
sarscov
vlp
enter
vero
cell
neutral
effici
compar
antibodi
inhibitori
effect
antivimentin
antibodi
also
observ
uptak
sarscov
spike
protein
vero
cell
pretreat
antivimentin
antibodi
rp
two
differ
dose
reduct
number
cell
uptook
sarscov
spike
protein
observ
respect
cell
pretreat
differ
dose
antivimentin
antibodi
v
show
declin
respect
fig
result
confirm
vimentin
critic
entri
sarscov
role
vimentin
cell
entri
sarscov
also
evid
knockdown
experi
vero
cell
infect
lentivirus
carri
shrna
specif
vimentin
shvima
shvimb
shvimc
display
remark
reduct
protein
express
vimentin
fig
cell
preinfect
lentivirus
carri
shvimc
reduc
express
vimentin
protein
undetect
level
reduct
uptak
sarscov
spike
protein
observ
fig
altogeth
surfac
vimentin
interact
directli
viral
spike
protein
complex
vero
cell
membran
involv
entri
process
sarscov
addit
sinc
shvima
knockeddown
vimentin
express
littl
effect
uptak
spike
protein
low
level
vimentin
protein
may
alreadi
suffici
facilit
entri
sarscov
previou
studi
demonstr
cell
fusion
occur
roughli
h
cocultur
viral
spikeexpress
cell
cellular
receptor
vero
cell
use
membraneinsolubl
crosslink
dtssp
captur
interact
protein
close
proxim
within
current
studi
vimentin
detect
min
treatment
vero
cell
purifi
viral
spike
protein
fig
followup
experi
demonstr
interact
sarscov
vlp
receptor
within
min
incub
fig
sinc
structur
sarscov
vlp
similar
sarscov
crownshap
appear
nm
diamet
propos
bind
topolog
conformationmimick
spike
protein
vlp
receptor
similar
topolog
sarscov
spike
protein
requir
shorter
period
time
partial
purifi
spike
protein
apart
aforement
reason
differ
experiment
condit
might
also
play
signific
role
vimentin
protein
appear
cellular
membran
sinc
cell
treat
purifi
sarscov
spike
protein
react
temperatur
fig
wherea
treat
sarscov
vlp
conduct
fig
previou
patholog
studi
indic
alveolar
epitheli
cell
essenti
cell
type
involv
sar
infect
subsequ
respiratori
failur
sinc
alveolar
epithelium
cell
differenti
type
type
ii
cell
cell
type
theoret
target
sarscov
infect
nevertheless
proven
larg
express
type
ii
cell
human
lung
thu
believ
primari
target
sarscov
propos
support
anoth
vitro
studi
human
alveolar
type
ii
cell
demonstr
suscept
sar
nucleocapsid
sarsn
protein
even
though
immunofluoresc
stain
fail
detect
vimentin
express
type
ii
cell
mention
studi
infect
sarscov
also
detect
primari
cultur
type
ilik
cell
replic
could
success
carri
addit
studi
pulmonari
stemprogenitor
cell
demonstr
capabl
differenti
alveolar
type
ii
type
ilik
pneumocyt
sequenti
cell
type
suscept
sarscov
infect
hand
clinic
vivo
studi
use
macaqu
monkey
model
indic
target
cell
sarscov
primarili
type
pneumocyt
studi
state
reveal
suscept
either
type
type
ii
alveolar
cell
sarscov
infect
still
controversi
among
differ
speci
top
mechan
stemprogenitor
cell
differenti
two
type
alveolar
cell
yet
clear
nevertheless
studi
support
role
vimentin
cell
entri
sarscov
data
also
provid
evid
sarscov
vlp
enhanc
express
vimentin
cell
membran
first
observ
toward
impact
vimentin
sarscov
cell
entri
although
potenti
extracellular
surfaceassoci
function
vimentin
report
previous
mycobacterium
tuberculosisinfect
monocyt
vimentin
act
ligand
receptor
natur
killer
cell
besid
one
previou
studi
demonstr
tail
region
surfac
vimentin
endotheli
target
cowpea
mosaic
viru
cpmv
infect
support
hypothesi
vimentin
function
import
viral
pathogenesi
furthermor
associ
vimentin
outer
capsid
protein
also
consid
essenti
bluetongu
viru
egress
one
exampl
african
swine
fever
viru
provid
detail
mechan
vimentin
viral
pathogenesi
suggest
phosphoryl
rearrang
vimentin
occur
viru
infect
vimentin
cage
subsequ
form
around
viru
assembl
site
later
stage
infect
research
vimentin
one
interact
partner
receptor
direct
contact
sarscov
spike
protein
yet
domain
vimentin
play
role
interact
viral
spike
protein
remain
unclear
moreov
whether
vimentin
bind
directli
arrang
close
proxim
need
confirm
mention
tail
region
vimentin
uniqu
conform
shown
import
cpmv
entri
potenti
associ
membran
protein
henc
hypothes
put
sarscov
spike
proteinbind
domain
may
resid
tail
region
vimentin
despit
fact
vimentin
known
intracellular
filament
cytoskelet
protein
recent
indic
secret
blood
endotheli
cell
activ
macrophag
golgi
apparatu
present
plasma
membran
previou
studi
also
suggest
vimentin
may
local
cell
membran
due
structur
highli
posit
charg
aminotermin
domain
tyrxxi
motif
x
amino
acid
bulki
hydrophob
amino
acid
follow
diacid
motif
aspxglu
contain
carboxi
terminu
furthermor
phosphoryl
vimentin
sever
protein
kinas
identifi
secret
vimentin
higher
level
phosphoryl
lower
appar
molar
mass
intracellular
form
evid
state
impli
secret
intracellular
vimentin
may
differenti
biolog
function
previous
demonstr
laboratori
sarscov
spike
protein
stimul
activ
signal
pathway
express
fibrosisassoci
phosphoryl
also
vimentin
identifi
receptor
interact
protein
involv
src
erk
signal
pathway
propos
rearrang
vimentin
intracellular
compart
cell
surfac
might
result
phosphoryl
vimentin
activ
raserk
signal
pathway
induc
interact
sarscov
spike
protein
cell
surfac
vimentin
particip
viral
entri
associ
complex
howev
whether
vimentin
involv
activ
downstream
signal
pathway
need
investig
studi
demonstr
cytoplasm
vimentin
transloc
cell
surfac
interact
complex
reveal
put
entri
pathway
sarscov
fig
studi
first
report
indic
vimentin
interact
directli
sarscov
spike
protein
bind
process
serv
put
coreceptor
involv
entri
sarscov
ultim
result
may
help
develop
new
drug
prevent
infect
sarscov
reduc
suscept
sarscov
infect
